Dr. Srinadh Komanduri, MD

Dr. Komanduri practices at Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois.

Dr. Komanduri's NPI, 1952342339, was assigned on June 9, 2006. Dr. Komanduri graduated from University of Miami, Lm Miller School of Medicine in 1997.

Dr. Komanduri's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD, at 259 E Erie St, Chicago, IL 60611.

Dr. Komanduri's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois. Dr. Komanduri is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Komanduri to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Komanduri's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Komanduri practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Komanduri's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Komanduri has a license on file in Illinois.

CMS data shows 749 Medicare services from Dr. Komanduri across 20 procedure codes in 2024, for 475 Medicare patients. Medicare paid $106,450 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 475 Medicare patients who saw Dr. Komanduri in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Komanduri's median patient age at 72, with 49% women.

In 2024, Dr. Komanduri wrote 775 Medicare Part D claims for 350 patients. 79% of them were for generic drugs. CMS names the drug for 698 of them, across 10 drugs with 11 or more claims each, at $105,618 in total drug cost. In 2023, CMS named 591 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Komanduri for performance year 2024, reported through an alternative payment model (APM). Dr. Komanduri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Komanduri as offering telehealth. CMS counts 526 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Komanduri, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 29 papers to Dr. Komanduri, published from 2017 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Barrett Esophagus, Esophageal Neoplasms and Esophagoscopy. Dr. Komanduri has published most often in Dis Esophagus. Dr. Komanduri's most frequent co-authors are Sachin Balkrishna Wani, MD, Dayna S. Early, MD and Samuel Y. Han, MD.

Dmand AI links Dr. Komanduri to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Barrett Esophagus and Precancerous Conditions. Open Payments lists research payments to Dr. Komanduri that name 1 trial.

CMS Open Payments shows 369 general payments to Dr. Komanduri from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $145,526. It also lists 1 research payment totaling $1,600 in 2016, naming 1 clinical trial.

Dr. Komanduri graduated from University of Miami, Lm Miller School of Medicine in 1997.